Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.40 +0.41 (+2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Gains from Sales and Divestitures (2020 - 2023)

Updated

Viridian Therapeutics, Inc.\DE's Gains from Sales and Divestitures was -$449,000 in FY2024, compared with -$1,000 in FY2023.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Gains from Sales and Divestitures (2020 - 2023) Analysis & Trends

  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$1,000 in FY2023 and -$77,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Viridian Therapeutics, Inc.\DE 2.20 Bn 2.20 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1,000.00
Dec 31, 2021 -2,000.00
Sep 30, 2021 -8,000.00
Jun 30, 2020 11,000.00
Mar 31, 2020 -11,000.00
API Access

Viridian Therapeutics, Inc.\DE Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VRDN&period=max&api_key=YOUR_API_KEY